Today: 13 May 2026
QXO stock drops on $750 million share sale pricing and early Q4 snapshot
16 January 2026
1 min read

QXO stock drops on $750 million share sale pricing and early Q4 snapshot

New York, Jan 16, 2026, 3:35 PM EST — Regular session

  • QXO shares dropped roughly 5% following the announcement of a $750 million common-stock offering priced at $23.80
  • Company reported preliminary fourth-quarter net sales around $2.19 billion, with adjusted EBITDA near $150 million
  • Investors are focused on the deal closing next week and potential acquisitions fueled by the new capital

Shares of QXO Inc fell Friday following the announcement of a $750 million common-stock offering. The building-products distributor also released a brief preliminary snapshot of its fourth-quarter results.

QXO’s current financing is crucial since the company has been raising funds to back acquisitions. Selling stock at a discount risks short-term price pressure as investors juggle concerns about dilution with the potential for growth from those deals.

QXO, under CEO Brad Jacobs, positions itself as a consolidator in building products distribution—a space marked by intense deal activity and sporadic fundraising surges.

The company set the price at $23.80 per share for 31,645,570 shares, aiming to wrap up the offering by Jan. 20. It granted the underwriter a green light to purchase up to 4,746,835 more shares. Proceeds are slated for general corporate uses, including potential acquisitions.

Thursday’s regulatory filing revealed a planned $750 million sale, with an option to raise an extra $112.5 million through the underwriter.

QXO reported preliminary, unaudited Q4 net sales near $2.19 billion and adjusted EBITDA around $150 million late Thursday. The company also said it plans to file its annual report by Feb. 26.

Adjusted EBITDA measures profit by excluding interest, taxes, and other factors companies argue can obscure true operating performance.

QXO shares slipped roughly 4.6% to $23.87 in afternoon trading, having dropped as low as $22.87 earlier.

Oppenheimer’s Scott Schneeberger bumped his price target on QXO to $30 from $27, describing the recent fundraising as a “positive catalyst” that points to “a deal is near,” according to Investing.com. Investing.com

Earlier this month, QXO announced new financing led by Apollo Global Management and Temasek aimed at supporting future acquisitions amid ongoing consolidation in building products and construction supply chains.

The immediate challenge lies in execution: additional equity raises could pressure the stock, early figures might shift, and the acquisition plan risks investor exposure if construction demand weakens or integration runs into trouble.

Traders are eyeing the offering’s close on Jan. 20 before shifting focus to the annual filing due Feb. 26 for a deeper dive into margins and cash flow. Any hint of a deal announcement in the meantime will also draw close attention.

Stock Market Today

No summaries found on the roundup post.

Latest article

US Stocks Lose Their Record Edge After Hours as Oil Turns Inflation Into a Fed Problem

US Stocks Lose Their Record Edge After Hours as Oil Turns Inflation Into a Fed Problem

13 May 2026
Tech stocks led declines Tuesday after April CPI data showed consumer prices rose 0.6% for the month and 3.8% year-over-year, pushing Treasury yields higher and weighing on rate-cut hopes. Brent crude settled above $107, fueling inflation concerns. The S&P 500 slipped 11.88 points to 7,400.96, while the Nasdaq lost 185.92 to 26,088.20. Chip stocks fell sharply, with Qualcomm down 11% and Intel off 6.8%.
Karman Stock’s Rally Turns Into an Earnings Test as Backlog Jumps and Valuation Bites

Karman Stock’s Rally Turns Into an Earnings Test as Backlog Jumps and Valuation Bites

13 May 2026
Karman Holdings shares closed up 6.2% at $62.48 on May 12, then fell 11% after hours following first-quarter results and a raised 2026 outlook. Q1 revenue jumped 51% to $151.2 million, net income reached $7.8 million, and backlog hit $1.0 billion. Adjusted EPS matched the $0.11 estimate. The company announced over $1 billion in new contingent demand commitments.
AbbVie stock slides on mixed lymphoma trial readout as investors eye the next catalyst
Previous Story

AbbVie stock slides on mixed lymphoma trial readout as investors eye the next catalyst

Western Digital (WDC) stock price: Analysts lift targets as SanDisk stake sale, earnings loom
Next Story

Western Digital (WDC) stock price: Analysts lift targets as SanDisk stake sale, earnings loom

Go toTop